Search

everythinglearnresearchcommunity

for

Search:↓

Stem cells slowed lung tumor growth but increased colon tumor growth in mice.

Topical metformin gel is as effective and safe as steroids for treating alopecia areata.

Tofacitinib is safe and effective for treating moderate-to-severe alopecia areata.

Ritlecitinib improves emotional well-being and activity levels in alopecia areata patients.

Alopecia areata is hard to treat, but new targeted therapies show promise.

Ruxolitinib cream may help treat severe hair loss in children.

rwSALT provides precise hair regrowth measurement from scalp photos.

rwSALT accurately measures hair regrowth in alopecia areata using scalp photos.

Oral and topical tofacitinib can effectively treat severe hair loss with minimal side effects.

Hair loss can indicate various health issues, including serious diseases, hormonal imbalances, and can significantly affect personal life and mental health.

Alopecia affects mental health, causing depression and anxiety, but new treatments can improve both hair growth and quality of life.

Alopecia affects mental health, causing depression and anxiety, but new treatments can help improve both hair growth and quality of life.

Janus kinase inhibitors can help children with alopecia areata regrow hair but may have some risks.

New treatments focusing on immune pathways show promise for stubborn hair loss.

Baricitinib for alopecia areata may rarely cause eye issues like keratitis.

Targeting SIRT1 with antisense oligonucleotides could be a promising treatment for hair loss.

Early genetic testing and JAK inhibitors can help treat systemic inflammation in SAVI patients.

Oral and topical tofacitinib can help regrow hair in people with severe alopecia areata.

The name Janus is fitting for JAK inhibitors as they revolutionize dermatology treatments.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

Rituximab may cause skin issues, but baricitinib can help improve them.

Recognizing scalp symptoms in PRP is crucial for proper diagnosis and treatment.

Alopecia areata is caused by immune system issues, and JAK inhibitors might help treat it.

Frontal fibrosing alopecia is linked to increased immune system activity and reduced stem cells, suggesting early treatment targeting this pathway might prevent hair follicle damage.

Tofacitinib may effectively treat folliculitis decalvans.

New treatments for hair loss are emerging as we better understand hair growth and its genetic causes.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

Enhancing Tregs can protect against alopecia areata.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.

New therapies like JAK inhibitors and stem cells show promise in treating vitiligo.